• David P. Perry
  Chief Executive Officer
• Karl R. Beutner, M.D., Ph.D.
  Senior Vice President and Chief Medical Officer
• Christine E. Gray-Smith
  Senior Vice President and Chief Financial Officer
• Kirk R. Maples, Ph.D.
  Senior Vice President, Program Management
• Jacob J. Plattner, Ph.D.
  Senior Vice President, Research
• Irwin A. Heyman, Ph.D.
  Senior Vice President, Product Development
• Kurt R. Jarnagin, Ph.D.
  Vice President, Biological Research
• James R. Marconi
  Vice President, Finance and Controller
• Lee T. Zane, M.D.
  Vice President, Clinical Development

Christine E. Gray-Smith
Senior Vice President and Chief Financial Officer

Christine E. Gray-Smith has served as Anacor's Senior Vice President, Chief Financial Officer since June 2007. From April 2004 to January 2007, Ms. Gray-Smith served as Executive Vice President and Chief Financial Officer of CoTherix, a biopharmaceutical company. From June 2001 to April 2004, Ms. Gray-Smith served as Chief Financial Officer of Triad Therapeutics, Inc., a biopharmaceutical company, and was promoted to Senior Vice President in 2003. Prior to Triad, Ms. Gray-Smith served as the senior financial officer at Calydon, a biotechnology company, and SUGEN, Inc. She also served in financial management roles in software companies. Ms. Gray-Smith also spent nine years with the international accounting firm of Arthur Young & Company (predecessor to Ernst & Young LLP). Ms. Gray-Smith holds a B.A. from the University of California, Berkeley and an M.B.A. from the Haas School of Business at the University of California, Berkeley.